ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

ASSOCIATION OF ANTHROPOMETRIC AND LIFESTYLE FACTORS WITH PROSTATE SPECIFIC ANTIGEN (PSA) TRAJECTORIES IN MEN WITH LOCALISED PROSTATE CANCER UNDERGOING ACTIVE MONITORING

Podrobná bibliografie
Hlavní autoři:	Burton, A, Martin, R, Holly, J, Hamdy, F, Neal, D, Donovan, J, Tilling, K
Médium:	Journal article
Vydáno:	2011

Podobné jednotky

Associations of lifestyle factors and anthropometric measures with repeat PSA levels during active surveillance/monitoring.
Autor: Burton, A, a další
Vydáno: (2012)

Associations of adiponectin and leptin with stage and grade of PSA-detected prostate cancer: the ProtecT study.
Autor: Burton, A, a další
Vydáno: (2013)

Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.
Autor: Tilling, K, a další
Vydáno: (2010)

Investigating the prostate specific antigen, body mass index and age relationship: is an age-BMI-adjusted PSA model clinically useful?
Autor: Harrison, S, a další
Vydáno: (2016)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
Autor: Catto, J, a další
Vydáno: (2011)

Suitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study
Autor: Catto, J, a další
Vydáno: (2011)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Autor: Young, GJ, a další
Vydáno: (2017)

Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis.
Autor: Roddam, A, a další
Vydáno: (2005)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Autor: Collin, S, a další
Vydáno: (2009)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
Autor: Wade, J, a další
Vydáno: (2015)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
Autor: Lane, J, a další
Vydáno: (2009)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
Autor: Hamdy, F, a další
Vydáno: (2006)

Metabolic imbalance and prostate cancer progression.
Autor: Burton, A, a další
Vydáno: (2010)

Variation in percentage-free prostate-specific antigen (PSA) with prostate volume, age and total PSA level.
Autor: Törnblom, M, a další
Vydáno: (2001)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
Autor: Ulrika Rönningås, a další
Vydáno: (2019-07-01)

Association between polymorphisms in the prostate-specific antigen (PSA) promoter and release of PSA.
Autor: Sävblom, C, a další
Vydáno: (2009)

Prostate Specific Antigen (PSA): The Historical Perspective
Autor: T. Ming Chu
Vydáno: (2020-12-01)

Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
Autor: Amit M. Algotar PhD, MBBS, a další
Vydáno: (2011-05-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
Autor: Lane, J, a další
Vydáno: (2004)

Uji diagnostik prostate spesific antigen (PSA) pada keganasan prostat
Autor: , DAHESIHDEWI, Andaru, a další
Vydáno: (2002)

Role of Prostate-Specific Antigen (PSA) in Patients with Benign Prostate Hyperplasia
Autor: Priya Duvedi, a další
Vydáno: (2019-05-01)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Autor: Avery, K, a další
Vydáno: (2007)

Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research
Autor: Littlejohns, T, a další
Vydáno: (2016)

Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia?
Autor: Jin-Woo Jung, a další
Vydáno: (2019-01-01)

Serum insulin-like growth factor-I is positively associated with serum prostate-specific antigen in middle-aged men without evidence of prostate cancer.
Autor: Oliver, SE, a další
Vydáno: (2004)

PSA testing for men at average risk of prostate cancer
Autor: Bruce K Armstrong, a další
Vydáno: (2017-07-01)

Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
Autor: Andrew J Simpkin, a další
Vydáno: (2015-07-01)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
Autor: Zuccolo, L, a další
Vydáno: (2013)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Autor: Lane, J, a další
Vydáno: (2007)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Autor: Harrison, S, a další
Vydáno: (2020)

Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Autor: Oliver, SE, a další
Vydáno: (2004)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Autor: Simpkin, A, a další
Vydáno: (2013)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Autor: Avery, K, a další
Vydáno: (2008)

Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
Autor: Blijenberg, BG, a další
Vydáno: (2003)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Autor: Down, L, a další
Vydáno: (2011)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Autor: Down, L, a další
Vydáno: (2011)

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT
Autor: Hamdy, FC, a další
Vydáno: (2020)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
Autor: Rosario, D, a další
Vydáno: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
Autor: Rosario, D, a další
Vydáno: (2012)